Impact of myosteatosis on skeletal muscle volume loss in patients with chronic liver disease

2018 ◽  
Vol 33 (9) ◽  
pp. 1659-1666 ◽  
Author(s):  
Yoshihiko Tachi ◽  
Akihiro Kozuka ◽  
Takanori Hirai ◽  
Yoji Ishizu ◽  
Takashi Honda ◽  
...  
Keyword(s):  
Skeletal Muscle ◽  
Liver Disease ◽  
Chronic Liver Disease ◽  
Muscle Volume ◽  
Chronic Liver ◽  
Volume Loss

Relative changes in handgrip strength and skeletal muscle volume in patients with chronic liver disease over a 2-year observation period

2018 ◽  
Vol 48 (7) ◽  
pp. 502-508 ◽  
Author(s):  
Atsushi Hiraoka ◽  
Kojiro Michitaka ◽  
Hirofumi Izumoto ◽  
Hidetaro Ueki ◽  
Shogo Kitahata ◽  
...  
Keyword(s):  
Skeletal Muscle ◽  
Liver Disease ◽  
Chronic Liver Disease ◽  
Handgrip Strength ◽  
Muscle Volume ◽  
Chronic Liver ◽  
Observation Period

SAT-047-Easy surveillance method without need of special equipment for muscle volume loss in patients with chronic liver disease

2019 ◽  
Vol 70 (1) ◽  
pp. e647-e648
Author(s):  
Atsushi Hiraoka ◽  
Kojiro Michitaka ◽  
Eiji Tsubouchi ◽  
Tomoyuki Ninomiya ◽  
Yohei Koizumi ◽  
...  
Keyword(s):  
Liver Disease ◽  
Chronic Liver Disease ◽  
Muscle Volume ◽  
Chronic Liver ◽  
Volume Loss ◽  
Special Equipment ◽  
Surveillance Method

scholarly journals Easy surveillance of muscle volume decline in chronic liver disease patients using finger‐circle ( yubi‐wakka ) test

2019 ◽  
Vol 10 (2) ◽  
pp. 347-354 ◽  
Author(s):  
Atsushi Hiraoka ◽  
Hirofumi Izumoto ◽  
Hidetaro Ueki ◽  
Takeaki Yoshino ◽  
Toshihiko Aibiki ◽  
...  
Keyword(s):  
Liver Disease ◽  
Chronic Liver Disease ◽  
Muscle Volume ◽  
Chronic Liver

scholarly journals Imaging Software-Based Sarcopenia Assessment in Gastroenterology: Evolution and Clinical Meaning

2021 ◽  
Vol 2021 ◽  
pp. 1-7
Author(s):  
Giovanni Marasco ◽  
Sinan Sadalla ◽  
Giulio Vara ◽  
Rita Golfieri ◽  
Davide Festi ◽  
...  
Keyword(s):  
Skeletal Muscle ◽  
Liver Disease ◽  
Liver Failure ◽  
Chronic Liver Disease ◽  
Liver Diseases ◽  
Chronic Liver ◽  
Chronic Liver Failure ◽  
Cross Sectional ◽  
Cross Sectional Imaging ◽  
Sectional Imaging

Sarcopenia is gaining attention as a negative prognostic factor in different fields of medicine, including chronic liver failure. However, the assessment of sarcopenia in patients with liver diseases is often neglected due to unawareness of reliable tools and methods and thus is limited to research studies. Cross-sectional imaging is a diffuse diagnostic tool and is commonly performed in patients with chronic liver failure. The last advancements in radiology image analysis using dedicated software allow an easy and standardized method to assess skeletal muscle volume. Several measures can be obtained from cross-sectional imaging analysis to evaluate sarcopenia in patients affected by chronic liver disease. We aimed to review the recent advances in imaging-based sarcopenia assessment, in particular in patients with chronic liver diseases. As a result, we found that the skeletal muscle index (SMI) seems to be a reliable method to assess sarcopenia in cirrhotic patients. Even if further studies are needed to validate proper cut-offs for each clinical endpoint, physicians are invited to consider the assessment of sarcopenia in the work-up of patients with chronic liver disease.

Calculated body muscle mass as a useful screening marker for low skeletal muscle mass and sarcopenia in chronic liver disease

2020 ◽  
Vol 50 (6) ◽  
pp. 704-714
Author(s):  
Tatsuki Ichikawa ◽  
Hisamitsu Miyaaki ◽  
Satoshi Miuma ◽  
Yasuhide Motoyoshi ◽  
Mio Yamashima ◽  
...  
Keyword(s):  
Skeletal Muscle ◽  
Liver Disease ◽  
Chronic Liver Disease ◽  
Muscle Mass ◽  
Skeletal Muscle Mass ◽  
Chronic Liver ◽  
Body Muscle ◽  
Screening Marker

Skeletal muscle fat deposition is associated with hepatocellular carcinoma development in patients with chronic liver disease

Nutrition ◽  
2018 ◽  
Vol 54 ◽  
pp. 83-88 ◽  
Author(s):  
Yoshihiko Tachi ◽  
Akihiro Kozuka ◽  
Takanori Hirai ◽  
Yuko Kojima ◽  
Yoji Ishizu ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Skeletal Muscle ◽  
Liver Disease ◽  
Chronic Liver Disease ◽  
Fat Deposition ◽  
Chronic Liver

Development of a simple predictive model for decreased skeletal muscle mass in patients with compensated chronic liver disease

2017 ◽  
Vol 47 (12) ◽  
pp. 1223-1234 ◽  
Author(s):  
Hiroki Nishikawa ◽  
Hirayuki Enomoto ◽  
Akio Ishii ◽  
Yoshinori Iwata ◽  
Yuho Miyamoto ◽  
...  
Keyword(s):  
Skeletal Muscle ◽  
Liver Disease ◽  
Chronic Liver Disease ◽  
Predictive Model ◽  
Muscle Mass ◽  
Skeletal Muscle Mass ◽  
Chronic Liver

scholarly journals Use of skeletal muscle index as a predictor of short-term mortality in patients with acute-on-chronic liver failure

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Tongzeng Li ◽  
Manman Xu ◽  
Ming Kong ◽  
Wenyan Song ◽  
Zhongping Duan ◽  
...  
Keyword(s):  
Skeletal Muscle ◽  
Liver Disease ◽  
Liver Failure ◽  
Chronic Liver Disease ◽  
Serum Bilirubin ◽  
Chronic Liver ◽  
Chronic Liver Failure ◽  
Short Term ◽  
Skeletal Muscle Index ◽  
Short Term Mortality

AbstractSarcopenia is a well-recognized factor affecting the prognosis of chronic liver disease, but its impact on acute decompensation underlying chronic liver disease is unknown. This study evaluated the impact of sarcopenia on short-term mortality in patients with acute-on-chronic liver failure (ACLF). One hundred and seventy-one ACLF patients who underwent abdominal CT between 2015 and 2019 were retrospectively included in this study. Skeletal muscle index at the third lumbar vertebrae (L3-SMI) was used to diagnose sarcopenia.The ACLF patients in this study had a L3-SMI of 41.2 ± 8.3 cm2/m2 and sarcopenia was present in 95/171 (55.6%) patients. Body mass index (BMI), cirrhosis, and higher serum bilirubin were independently associated with sarcopenia. Following multivariate Cox regression analysis, cirrhosis (hazard ratio (HR) 2.758, 95%CI 1.323–5.750), serum bilirubin (HR 1.049, 95%CI 1.026–1.073), and international normalized ratio (INR) (HR 1.725, 95%CI 1.263–2.355) were associated with 3-month mortality (P < 0.05), whereas L3-SMI and sarcopenia were not. A subgroup analysis of the factors related to sarcopenia showed that sarcopenia was still not predictive of short-term outcome in ACLF patients. L3-SMI and sarcopenia are not associated with short-term mortality in patients with ACLF.

Loss of skeletal muscle mass in patients with chronic liver disease is related to decrease in bone mineral density and exercise tolerance

2017 ◽  
Vol 48 (5) ◽  
pp. 345-354 ◽  
Author(s):  
Fumikazu Hayashi ◽  
Masaki Kaibori ◽  
Tatsuma Sakaguchi ◽  
Kosuke Matsui ◽  
Morihiko Ishizaki ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Skeletal Muscle ◽  
Liver Disease ◽  
Chronic Liver Disease ◽  
Muscle Mass ◽  
Bone Mineral ◽  
Exercise Tolerance ◽  
Skeletal Muscle Mass ◽  
Chronic Liver ◽  
Mineral Density
Sign in / Sign up

Export Citation Format

Share Document